Global Transdermal Patches Market Size study & Forecast, by Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix and Others) by Application (Cardiovascular, Central Nervous System, Pain Management, Dermatology and Others) by Technolog

Global Transdermal Patches Market Size study & Forecast, by Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix and Others) by Application (Cardiovascular, Central Nervous System, Pain Management, Dermatology and Others) by Technology (Electric current, Mechanical arrays, Thermal Ablation, Chemical Enhancers and Others) and Regional Analysis, 2022-2029

Global Transdermal Patches Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Transdermal patches are a form of medicated adhesive patch. Utilizing diffusion technique and transdermal technology, they assist in delivering a predetermined amount of medication to the body. The drug gradually enters the blood stream over time. These patches are used for treating a variety of illnesses, including migraines, diabetes, Alzheimer's, cardiac problems, and hormone issues. The Transdermal Patches market is expanding because of factors such as rising prevelance of chronic disorders and rising technological advancement in transdermal drug delivery systems.

Rising prevelance of chronic diseases such as diabetes and other neurological disorders such as migraine, Alzheimer’s and other is driving the market growth. According to IDF, International Diabetic federation it is estimated that there will be more than about 578 million population (adults) with diabetes by 2030, and 700 million by 2045. Along with these, according to report from Alzhemier Disease International Organization, in year 2020, there were around 55 million people worldwide suffering from dementia and this figure is expected to reach at 78 million in year 2030 and 139 million by year 2050. Thus, rising prevalence of chronic disorder is fostering the market growth. In addition, increasing non-invasive and painless medication administration and rising product development activities is creating a lucrative growth to the market. However, the high cost of transdermal patches and increasing development of contact dermatitis or other skin infections stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Transdermal Patches Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas, Asia Pacific is expected to grow with a fastest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
AdhexPharma
ProSolus Inc.
Tapemark Company Inc
Tesa Labtec GmbH
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
LTS Lohmann Therapie-Systeme AG
Therapie-Systeme AG
Medherant Limited
Corium International, Inc.

Recent Developments in the Market:
In June 2019, Toa Eiyo and Astellas Pharma Inc. have launched BisonoTM Tape 2mg transdermal patches, which were created in collaboration with Toa Eiyo Ltd. and contain a 1 blocker. With the inclusion of these dosages, BisonoTM Tape 2mg, 4mg, and 8mg will benefit patients who have atrial fibrillation and have trouble swallowing oral medications by enhancing medication adherence and consequently supporting the continuation of treatment for this population of patients.

Global Transdermal Patches Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Application, Technology, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Typeofferings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Matrix
Others

By Application:
Cardiovascular
Central Nervous System
Pain Management
Dermatology
Others
By Technology:
Electric current
Mechanical arrays
Thermal Ablation
Chemical Enhancers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

AdhexPharma
ProSolus Inc.
Tapemark Company Inc
Tesa Labtec GmbH
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
LTS Lohmann Therapie-Systeme AG
Therapie-Systeme AG
Medherant Limited
Corium International, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.